ONC establishes disciplinary procedure for ONC-AA

The Office of the National Coordinator for Health IT (ONC) recently unveiled a final rule that further details the responsibilities of the ONC-Approved Accreditor (ONC-AA) and outlines a process for disciplinary action should the ONC-AA fail to meet those responsibilities. 

The ONC, which was authorized by the HITECH Act to implement a certification program for health IT products, instituted a temporary health IT certification program in June 2010, but the final rule, published Nov. 25 in the Federal Register, defines the ONC’s future role as the disciplinarian in a permanent certification program that will begin in summer 2012.

According to the requirements of the proposed permanent certification program, a single entity will serve at a given time as the sole ONC-AA responsible for accrediting other entities as ONC-Authorized Certification Bodies (ONC-ACB), qualifying them to certify certain health IT products as in compliance or not in compliance with meaningful use criteria.

The final rule regarding the ONC-AA stipulated that the ONC can revoke the accrediting entity’s power if it “engages in improper conduct or does not perform its responsibilities under the permanent certification program.” The ONC-AA will be subject to discipline for conduct violations, such as noncompliance with laws or with the permanent certification program’s policies, or performance violations such as a failure to properly monitor ONC-ACBs.

If an entity is removed as ONC-AA, it will be allowed an opportunity for appeal and for readmission as the ONC-AA following a year of suspension.



Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.